BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 16720112)

  • 1. Characterisation of an industrial affinity process used in the manufacturing of digoxin-specific polyclonal Fab fragments.
    Thillaivinayagalingam P; O'Donovan K; Newcombe AR; Keshavarz-Moore E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Mar; 848(1):88-96. PubMed ID: 16720112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection and quantification of affinity ligand leaching and specific antibody fragment concentration within chromatographic fractions using surface plasmon resonance.
    Thillaivinayagalingam P; Newcombe AR; O'Donovan K; Francis R; Keshavarz-Moore E
    Biotechnol Appl Biochem; 2007 Dec; 48(Pt 4):179-88. PubMed ID: 17516918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decision-support software for the industrial-scale chromatographic purification of antibodies.
    Chhatre S; Thillaivinayagalingam P; Francis R; Titchener-Hooker NJ; Newcombe AR; Keshavarz-Moore E
    Biotechnol Prog; 2007; 23(4):888-94. PubMed ID: 17630695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global Sensitivity Analysis for the determination of parameter importance in bio-manufacturing processes.
    Chhatre S; Francis R; Newcombe AR; Zhou Y; Titchener-Hooker N; King J; Keshavarz-Moore E
    Biotechnol Appl Biochem; 2008 Oct; 51(Pt 2):79-90. PubMed ID: 18205624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a novel agarose-based synthetic ligand adsorbent for the recovery of antibodies from ovine serum.
    Chhatre S; Francis R; Titchener-Hooker NJ; Newcombe AR; Keshavarz-Moore E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Dec; 860(2):209-17. PubMed ID: 18024245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Purification of antibody Fab and F(ab')2 fragments using Gradiflow technology.
    Cheung GL; Thomas TM; Rylatt DB
    Protein Expr Purif; 2003 Nov; 32(1):135-40. PubMed ID: 14680950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The integrated simulation and assessment of the impacts of process change in biotherapeutic antibody production.
    Chhatre S; Jones C; Francis R; O'Donovan K; Titchener-Hooker N; Newcombe A; Keshavarz-Moore E
    Biotechnol Prog; 2006; 22(6):1612-20. PubMed ID: 17137309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Purification and characterization of rabbit anti-mouse renin specific Fab fragments.
    Lykkegård S
    Acta Pathol Microbiol Scand C; 1979 Apr; 87C(2):91-7. PubMed ID: 443051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of thiophilic adsorption chromatography for the one-step purification of a bacterially produced antibody F(ab) fragment without the need for an affinity tag.
    Fiedler M; Skerra A
    Protein Expr Purif; 1999 Dec; 17(3):421-7. PubMed ID: 10600461
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of non-digitalis binding properties of digoxin-specific Fabs using direct binding methods.
    Pullen MA; Harpel MR; Danoff TM; Brooks DP
    J Immunol Methods; 2008 Jul; 336(2):235-41. PubMed ID: 18555269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Two routes for production and purification of Fab fragments in biopharmaceutical discovery research: Papain digestion of mAb and transient expression in mammalian cells.
    Zhao Y; Gutshall L; Jiang H; Baker A; Beil E; Obmolova G; Carton J; Taudte S; Amegadzie B
    Protein Expr Purif; 2009 Oct; 67(2):182-9. PubMed ID: 19442740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of monoclonal antidigoxin antibodies immobilized to a solid support.
    Brizgys MV; Pincus SH; Rollins DE
    Biotechnol Appl Biochem; 1988 Aug; 10(4):373-84. PubMed ID: 3219196
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enantioselective affinity chromatography of a chiral drug by crystalline and carrier-bound antibody fab fragment.
    Vuolanto A; Leisola M; Jokela J
    Biotechnol Prog; 2004; 20(3):771-6. PubMed ID: 15176881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Purification of Natural and Recombinant Peptide Antibodies by Affinity Chromatographic Strategies.
    Ma H; O'Kennedy R
    Methods Mol Biol; 2015; 1348():153-65. PubMed ID: 26424271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ultra scale-down approach for the prediction of full-scale recovery of ovine polycolonal immunoglobulins used in the manufacture of snake venom-specific Fab fragment.
    Neal G; Christie J; Keshavarz-Moore E; Shamlou PA
    Biotechnol Bioeng; 2003 Jan; 81(2):149-57. PubMed ID: 12451551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of a novel affinity adsorbent for the capture and purification of recombinant factor VIII compounds.
    McCue JT; Selvitelli K; Walker J
    J Chromatogr A; 2009 Nov; 1216(45):7824-30. PubMed ID: 19800068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification of Fab fragments from a monoclonal antibody papain digest by Gradiflow electrophoresis.
    Coleman L; Mahler SM
    Protein Expr Purif; 2003 Dec; 32(2):246-51. PubMed ID: 14965770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capture of human Fab fragments by expanded bed adsorption with a mixed mode adsorbent.
    Hansen MB; Lihme A; Spitali M; King D
    Bioseparation; 1999; 8(1-5):189-93. PubMed ID: 10734570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improving affinity chromatography resin efficiency using semi-continuous chromatography.
    Mahajan E; George A; Wolk B
    J Chromatogr A; 2012 Mar; 1227():154-62. PubMed ID: 22265178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The affinity of binding of digoxin to ovine anti-digoxin Fab (DIGIBIND) preparations.
    Allen G
    Biologicals; 1996 Mar; 24(1):19-24. PubMed ID: 8733598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.